A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

The requested reference [d7c9860cbe9c547a1e943584b86b48dd1e5473ff] no longer exists in our database. It has been replaced by the current reference: [51c632aeff900d42c712da0b3be5c378408c7bb8]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This clinical trial is a Phase 2/3 study that will evaluate the efficacy and safety of etavopivat and test how well etavopivat works compared to placebo to improve the amount of hemoglobin in the blood and to reduce the number of vaso-occlusive crises (times when the blood vessels become blocked and cause pain).
Epistemonikos ID: 594acfc6513c6ff3f4f572c0bf459726c1ba8d37
First added on: May 07, 2024